CN102405229A - 作为甲状旁腺激素(pth)受体激动剂的短链肽 - Google Patents

作为甲状旁腺激素(pth)受体激动剂的短链肽 Download PDF

Info

Publication number
CN102405229A
CN102405229A CN2010800175792A CN201080017579A CN102405229A CN 102405229 A CN102405229 A CN 102405229A CN 2010800175792 A CN2010800175792 A CN 2010800175792A CN 201080017579 A CN201080017579 A CN 201080017579A CN 102405229 A CN102405229 A CN 102405229A
Authority
CN
China
Prior art keywords
aib
phe
nle
eiq
har
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800175792A
Other languages
English (en)
Chinese (zh)
Inventor
拉杰什·巴赫卡尔
穆库尔·R·贾因
潘卡伊·R·帕特尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zydus Lifesciences Ltd
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Publication of CN102405229A publication Critical patent/CN102405229A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN2010800175792A 2009-04-24 2010-04-26 作为甲状旁腺激素(pth)受体激动剂的短链肽 Pending CN102405229A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN1095/MUM/2009 2009-04-24
IN1095MU2009 2009-04-24
IN225MU2010 2010-01-28
IN225/MUM/2010 2010-01-28
PCT/IN2010/000264 WO2010128521A2 (en) 2009-04-24 2010-04-26 Short-chain peptides as parathyroid hormone (pth) receptor agonist

Publications (1)

Publication Number Publication Date
CN102405229A true CN102405229A (zh) 2012-04-04

Family

ID=43050579

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800175792A Pending CN102405229A (zh) 2009-04-24 2010-04-26 作为甲状旁腺激素(pth)受体激动剂的短链肽

Country Status (15)

Country Link
US (1) US8383581B2 (cg-RX-API-DMAC7.html)
EP (1) EP2421893A2 (cg-RX-API-DMAC7.html)
JP (1) JP5744844B2 (cg-RX-API-DMAC7.html)
KR (1) KR101451470B1 (cg-RX-API-DMAC7.html)
CN (1) CN102405229A (cg-RX-API-DMAC7.html)
AU (1) AU2010245642A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI1008103A2 (cg-RX-API-DMAC7.html)
CA (1) CA2757874C (cg-RX-API-DMAC7.html)
EA (1) EA022212B1 (cg-RX-API-DMAC7.html)
IL (1) IL215625A (cg-RX-API-DMAC7.html)
MX (1) MX2011010968A (cg-RX-API-DMAC7.html)
NZ (1) NZ595437A (cg-RX-API-DMAC7.html)
SG (1) SG174532A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010128521A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201107078B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928487A (en) * 1974-11-27 1975-12-23 Standard Oil Co Alkylation process utilizing hydrofluoric acid with a minor amount of fluorosulfuric acid
UY32099A (es) 2008-09-11 2010-04-30 Enanta Pharm Inc Inhibidores macrocíclicos de serina proteasas de hepatitis c
CN103534256B (zh) 2010-12-30 2016-08-10 益安药业 大环丙型肝炎丝氨酸蛋白酶抑制剂
KR20140003521A (ko) 2010-12-30 2014-01-09 이난타 파마슈티칼스, 인코포레이티드 페난트리딘 매크로사이클릭 c형 간염 세린 프로테아제 억제제
WO2012120532A2 (en) 2011-02-02 2012-09-13 Cadila Healthcare Limited Cyclic short chain peptides
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
AU2024236908A1 (en) * 2023-03-16 2025-09-11 The Florey Institute Of Neuroscience And Mental Health Stapled peptides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003009804A2 (en) * 2001-07-23 2003-02-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
WO2004067021A1 (en) * 2003-01-24 2004-08-12 Gardella Thomas J Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
US20070111946A1 (en) * 1998-10-22 2007-05-17 Gardella Thomas J Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE412670T1 (de) * 1999-09-29 2008-11-15 Gen Hospital Corp Parathyroid hormon (pth) polypeptidderivate
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
AU2002951372A0 (en) 2002-09-13 2002-09-26 St Vincent's Institute Of Medical Research Parathyroid hormone-like polypeptides
AU2003220380A1 (en) * 2003-03-19 2004-11-19 Bristol-Myers Squibb Company CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH Alpha-HELIX STABILIZERS
EP1653985A4 (en) 2003-07-17 2009-08-05 Gen Hospital Corp FORCED PARATHORMON (PTH) ANALOGUE
EP1713815A4 (en) 2004-02-11 2009-03-11 Smithkline Beecham Corp PTH AGONISTS
WO2005077918A1 (en) 2004-02-11 2005-08-25 Smithkline Beecham Corporation Pth agonists
ITMI20041440A1 (it) 2004-07-19 2004-10-19 Abiogen Pharma Spa Peptidi analoghi del pth-1-11
CA2621264A1 (en) 2005-09-06 2007-11-15 Zelos Therapeutics, Inc. Parathyroid hormone analogues and methods of use
EP1961765A1 (en) 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
BRPI0814962B8 (pt) * 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070111946A1 (en) * 1998-10-22 2007-05-17 Gardella Thomas J Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
WO2003009804A2 (en) * 2001-07-23 2003-02-06 The General Hospital Corporation Conformationally constrained parathyroid hormone (pth) analogs
WO2004067021A1 (en) * 2003-01-24 2004-08-12 Gardella Thomas J Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges

Also Published As

Publication number Publication date
NZ595437A (en) 2014-03-28
ZA201107078B (en) 2014-03-26
JP5744844B2 (ja) 2015-07-08
MX2011010968A (es) 2012-01-19
KR20120034606A (ko) 2012-04-12
US8383581B2 (en) 2013-02-26
EA022212B1 (ru) 2015-11-30
BRPI1008103A2 (pt) 2016-05-03
IL215625A0 (en) 2012-01-31
AU2010245642A1 (en) 2011-10-27
CA2757874A1 (en) 2010-11-11
US20120108496A1 (en) 2012-05-03
IL215625A (en) 2016-12-29
SG174532A1 (en) 2011-10-28
EP2421893A2 (en) 2012-02-29
JP2012524775A (ja) 2012-10-18
WO2010128521A3 (en) 2011-03-10
KR101451470B1 (ko) 2014-10-15
CA2757874C (en) 2016-02-16
WO2010128521A2 (en) 2010-11-11
EA201171292A1 (ru) 2012-05-30

Similar Documents

Publication Publication Date Title
Bourgault et al. Novel stable PACAP analogs with potent activity towards the PAC1 receptor
RU2669999C2 (ru) Полипептиды
KR0173478B1 (ko) 부갑상선 호르몬 길항물질
JP5744844B2 (ja) 副甲状腺ホルモン(pth)受容体アゴニストとしての短鎖ペプチド
JP4541899B2 (ja) ラクタム架橋を有する、コンホメーションが制限された副甲状腺ホルモン(pth)アナログ
SK155694A3 (en) Glucagon-like peptide, insulinotropin derivatives, method of their preparation, pharmaceutical agent containing and using these matters
US20090264365A1 (en) Conformationally constrained parathyroid hormone (pth) analogs
JP4334480B2 (ja) α−ヘリックス安定化剤を用いる高次構造的に制約された副甲状腺ホルモン
JP7661478B2 (ja) 可溶性npy2受容体アゴニスト
WO2001070769A1 (fr) Derive peptidique
US20140057833A1 (en) Adiponectin receptor agonists and methods of use
JPS63313800A (ja) 副甲状腺ホルモン拮抗剤
Dong et al. Engineering of therapeutic polypeptides through chemical synthesis: early lessons from human parathyroid hormone and analogues
WO1998005683A1 (en) Parathyroid hormone analogues for the treatment of osteoporosis
JP2026026081A (ja) Npy2受容体アゴニスト
CN103501801A (zh) 甲状旁腺激素类似物、其组合物和用途
WO1996003437A1 (en) PTH OR PTHrP ANTAGONISTS
US20110195900A1 (en) Peptidic pth receptor agonists
EP4545553A2 (en) Peptide compound and application thereof, and composition containing peptide compound
Raisz et al. Comparison of the effects of a potent synthetic analog of bovine parathyroid hormone with native bPTH-(1-84) and synthetic bPTH-(1-34) on bone resorption and collagen synthesis
WO2012120532A2 (en) Cyclic short chain peptides
HK1168863A (en) Short-chain peptides as parathyroid hormone (pth) receptor agonist
Rajeswaran et al. Exploration of the DTrp-NMeLys motif in the search for potent somatostatin antagonists
WO2026098717A1 (zh) 一种多肽化合物及其制备方法、药物组合物和用途
EA049057B1 (ru) Растворимые агонисты рецепторов npy2

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1168863

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20120404

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1168863

Country of ref document: HK